Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.

about

THE CREATIVE PSYCHOSOCIAL GENOMIC HEALING EXPERIENCE (CPGHE) AND GENE EXPRESSION IN BREAST CANCER PATIENTS: A FEASIBILITY STUDY

P2860

Q57146537-DFA14D6B-D34F-4D09-A50D-49990A1E1010

P2860

Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.

Item

http://www.wikidata.org/entity/Q39212333

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Systemic therapies and cogniti ...... iew of the current literature.

@en

Systemic therapies and cogniti ...... iew of the current literature.

@nl

type

Item

label

Systemic therapies and cogniti ...... iew of the current literature.

@en

Systemic therapies and cogniti ...... iew of the current literature.

@nl

prefLabel

Systemic therapies and cogniti ...... iew of the current literature.

@en

Systemic therapies and cogniti ...... iew of the current literature.

@nl

P1476

Systemic therapies and cogniti ...... view of the current literature

@en

P2093

Agnese Vannini

http://www.w3.org/2001/XMLSchema#string

Giulio Francolini

http://www.w3.org/2001/XMLSchema#string

Lorenzo Livi

http://www.w3.org/2001/XMLSchema#string

Marco Perna

http://www.w3.org/2001/XMLSchema#string

Pietro Garlatti

http://www.w3.org/2001/XMLSchema#string

Roberta Grassi

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study

The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.

Estrogen- and tamoxifen-associated effects on brain structure and function.

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.

An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Objectively measured physical activity and cognitive functioning in breast cancer survivors

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

P2888

s12032-017-0935-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-0935-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Icro Meattini

Isacco Desideri

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28364269

http://www.w3.org/2001/XMLSchema#string

Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.

about

P2860

P2860

Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698